Published Date: 03-07-2017
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Diabetic Footwear Market, published by KBV Research, the Asia Pacific Diabetic Footwear Market is expected to register a CAGR of 9.7% during the forecast period (2017 - 2023).
The Shoes market dominated the Asia Pacific Diabetic Footwear Market by Type in 2016, and would continue to be a dominant market till 2023. The Sandals & Slippers market is expected to witness a CAGR of 9.2% during (2017 - 2023).
The China market dominated the Asia Pacific Diabetic Footwear in Online Stores Market by Country in 2016, and would continue to be a dominant market till 2023; growing at a CAGR of 8.4 % during the forecast period. The Japan market is expected to witness a CAGR of 11.2% during (2017 - 2023). Additionally, The India market is expected to witness a CAGR of 11.4% during (2017 - 2023).
The Women market dominated the South Korea Diabetic Footwear Market by End User in 2016, and would continue to be a dominant market till 2023. The Men market would achieve a market value of $67.6 million by 2023.
The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the Asia Pacific Diabetic Footwear have been discussed in the report along with the elaborated company profiles of New Balance Athletics, Inc., Skechers U.S.A. Inc. , Aetrex Industries, Inc., Orthofeet, Inc., DJO Asia Pacific, Inc., Drew Shoe Corporation, Wolverine Worldwide(Hush Puppies), and Dr. Zen Products, Inc.
Full report - https://www.kbvresearch.com/asia-pacific-diabetic-footwear-market/
Asia Pacific Diabetic Footwear Segmentation
By Types
By End Users
By Distribution Channels
By Countries
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Diabetic Footwear Market
Latin America, Middle East and Africa Diabetic Footwear Market